{
    "Trade/Device Name(s)": [
        "Actalyke QC Kits AQC-HP",
        "Actalyke QC Kits AQC-LP"
    ],
    "Submitter Information": "",
    "510(k) Number": "K061014",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "21 March 2006",
    "Summary Letter Received Date": "13 April 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose System for In Vitro Coagulation Studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Actalyke Activated Clotting Time test systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Actalyke QC Kits AQC-HP and AQC-LP as quality control for Actalyke Activated Clotting Time test systems",
    "Indications for Use Summary": "Used to perform quality control assays with Actalyke Activated Clotting Time test systems when monitoring heparinized patients undergoing ECMO, renal dialysis, or cardiovascular procedures",
    "fda_folder": "Hematology"
}